−0.3028 USD
−4.30 M USD
1.71 M USD
16.58 M
About Elevai Labs, Inc.
Sector
Industry
CEO
Graydon Bensler
Website
Headquarters
Newport Beach
Founded
2020
FIGI
BBG01JLC7VG4
Elevai Labs, Inc. is a physician-dispensed skincare company, which engages in the research and development of skincare formulations. It is involved in the production and commercialization of topical skincare products that contain its proprietary stem cell-derived Elevai Exosomes. The company was founded by Hatem Abou-Sayed and Jordan R. Plews in 2020 and is headquartered in Newport Beach, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ELAB is 0.0189 USD — it has increased by 0.56% in the past 24 hours. Watch Elevai Labs, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Elevai Labs, Inc. stocks are traded under the ticker ELAB.
ELAB stock has fallen by −72.20% compared to the previous week, the month change is a −82.10% fall, over the last year Elevai Labs, Inc. has showed a −99.53% decrease.
ELAB reached its all-time high on Nov 27, 2023 with the price of 4.2442 USD, and its all-time low was 0.0283 USD and was reached on Nov 1, 2024. View more price dynamics on ELAB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ELAB stock is 15.85% volatile and has beta coefficient of 1.23. Track Elevai Labs, Inc. stock price on the chart and check out the list of the most volatile stocks — is Elevai Labs, Inc. there?
Today Elevai Labs, Inc. has the market capitalization of 372.40 K, it has increased by 0.76% over the last week.
Yes, you can track Elevai Labs, Inc. financials in yearly and quarterly reports right on TradingView.
ELAB net income for the last quarter is −1.41 M USD, while the quarter before that showed −1.40 M USD of net income which accounts for −1.09% change. Track more Elevai Labs, Inc. financial stats to get the full picture.
No, ELAB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 8, 2024, the company has 18.00 employees. See our rating of the largest employees — is Elevai Labs, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Elevai Labs, Inc. EBITDA is −4.90 M USD, and current EBITDA margin is −218.87%. See more stats in Elevai Labs, Inc. financial statements.
Like other stocks, ELAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Elevai Labs, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Elevai Labs, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Elevai Labs, Inc. stock shows the neutral signal. See more of Elevai Labs, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.